Recurrent Colon Cancer, Recurrent Rectal Cancer, Stage IVA Colon Cancer, Stage IVA Rectal Cancer, Stage IVB Colon Cancer and Stage IVB Rectal Cancer Clinical Trial Using ziv-aflibercept, leucovorin calcium, irinotecan hydrochloride and fluorouracil

- The folks at City of Hope Medical Center are studying the effects of ziv-aflibercept; leucovorin calcium; irinotecan hydrochloride; fluorouracil on Recurrent Colon Cancer, Recurrent Rectal Cancer, Stage IVA Colon Cancer, Stage IVA Rectal Cancer, Stage IVB Colon Cancer and Stage IVB Rectal Cancer in individuals ages 18 years and older. This clinical trial is slated to start January 2014.

Overall Study Contact Info
StatusName Contact Phone
Recruiting

This study is officially titled, "A Prospective Study of Short Infusion of Ziv-Aflibercept in Combination With FOLFIRI in Patients With Metastatic Colorectal Cancer."

Locations

City of Hope Medical Center

Duarte, California - Recruiting

City of Hope- South Pasadena Cancer Center

South Pasadena, California - Recruiting

For more study details, please visit this link to ClinicalTrials.gov record, which is the source of this webpage.